MRI-guided Personalized Targeting of the Ventral Intermediate Nucleus (VIM)/Dentato-rubro-thalamic Tract (DRT) for the MRgFUS Tremor Treatment
The purpose of this investigation is to determine the optimal DRT/VIM target location and its safety margins based on MR-SISET imaging features by comparing with postoperative lesions and clinical outcomes in patients with tremor who will undergo the MRgFUS tremor therapy.
• Male or female
• 18 years of age or older
• Any ethnic background
• History of a primary diagnosis of essential tremor or Parkinson's disease
• Present for the MRgFUS tremor treatment
• Ability to understand and agree to informed consent as determined by referring physician